Health, Fitness & Food

In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets for some of our biggest stocks. Many of these moves stemmed from what we saw in quarterly numbers and heard on conference calls. Here’s a day-by-day look at the portfolio action. Monday The week began with our decision to exit

A RSV-infected child receives treatment, as RS-Virus infections spread among children at Missio children’s clinic Moenchberg, in Wuerzburg, Germany, December 2, 2022.  Heiko Becker | Reuters Americans may soon have access to a shot that protects babies from respiratory syncytial virus, or RSV, the leading cause of hospitalization among infants in the U.S. A panel

Troubled Club holding Bausch Health Companies (BHC) reported better-than-expected quarterly results before the bell Thursday. However, it’s not nearly enough to get this stock out of the penalty box. Sales in the second quarter rose 10% to $2.17 billion, exceeding expectations of $2.04 billion, according to estimates compiled by Refinitiv. (On an organic basis —

Signage is seen outside the U.S. Food and Drug Administration headquarters in White Oak, Maryland, Aug. 29, 2020. Andrew Kelly | Reuters The U.S. Food and Drug Administration has warned that some Tydemy birth control pills may not be effective, several days after the manufacturer recalled two batches of the medication that were distributed in

In this article HUM Follow your favorite stocksCREATE FREE ACCOUNT A Humana office in Louisville, Kentucky, July 31, 2023. Jon Cherry | Bloomberg | Getty Images Humana shares rose Wednesday after the health insurer said medical costs came in lower than expected during its second-quarter earnings report. The results ease investor concerns two months after

In this article CVS Follow your favorite stocksCREATE FREE ACCOUNT A woman walks past a CVS Pharmacy in Washington, D.C., on Nov. 2, 2022. Brendan Smialowski | AFP | Getty Images CVS Health is cutting 5,000 jobs to reduce costs as the retail pharmacy giant furthers its push into health-care offerings, a person familiar with

In this article WBA Follow your favorite stocksCREATE FREE ACCOUNT Respiratory syncytial virus viral vaccine under research. Hailshadow | Istock | Getty Images Walgreens is now offering the respiratory syncytial virus vaccine for older adults nationwide, the pharmacy chain said on Tuesday. People ages 60 and older can schedule an appointment this week through Walgreens’

In this article PFE Follow your favorite stocksCREATE FREE ACCOUNT Paxlovid, Pfizer’s anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022. Wolfgang Rattay | Reuters The National Institutes of Health said Monday it launched mid-stage clinical trials to test at least four treatments, including Pfizer‘s antiviral

Shortly after the opening bell, we will be exiting our position in Johnson & Johnson (JNJ), selling 500 shares at roughly $171 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will no longer own a position in J & J. We are making the tough decision to exit our J & J position after the

Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy. Stefan Trumpf | Picture Alliance | Getty Images Danish pharmaceutical giant Novo Nordisk is set to launch its hugely popular Wegovy obesity drug in Germany this month, but it could be some time before

In this article PFE MRNA NVAX Follow your favorite stocksCREATE FREE ACCOUNT A pharmacist delivers a COVID-19 booster dose at a Chicago CVS store. Antonio Perez | Tribune News Service | Getty Images A new round of Covid vaccines is coming to the U.S. this fall — but many Americans may not roll up their

In this article JNJ Follow your favorite stocksCREATE FREE ACCOUNT In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San Anselmo, California.  Justin Sullivan | Getty Images A federal bankruptcy judge on Friday rejected Johnson & Johnson‘s second attempt to resolve tens of thousands of

Attendees walk through an expo hall during Amazon Web Services’ Reinvent conference at the Venetian in Las Vegas on Nov. 29, 2022. Noah Berger | Getty Images Entertainment | Getty Images Amazon Web Services on Wednesday announced a new service for health care software providers called AWS HealthScribe, which uses generative artificial intelligence and speech recognition to

Halfpoint Images | Moment | Getty Images The Americans with Disabilities Act was signed into law 33 years ago to protect people with disabilities from discrimination. But the disabled still face major hurdles when it comes to building wealth. To help make it easier for disabled individuals with lower incomes to save, Sen. Bob Casey,

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, September 17, 2020. Mike Blake | Reuters An Eli Lilly experimental drug helped patients lose about 26% of their weight on average following extended use or intensive lifestyle changes,

In this article NOVO.B-DK SAN-FR Follow your favorite stocksCREATE FREE ACCOUNT Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy. Stefan Trumpf | Picture Alliance | Getty Images U.K. health authorities on Wednesday said they are reviewing obesity and diabetes drugs like Novo

In this article GSK GSK-GB Follow your favorite stocksCREATE FREE ACCOUNT Budrul Chukrut | Lightrocket | Getty Images GlaxoSmithKline CEO Emma Walmsley on Wednesday said she expects uptake for the company’s new RSV vaccine to start off slower than it did for its blockbuster shingles shot. But she is confident that the new vaccine will

In this article BIIB Follow your favorite stocksCREATE FREE ACCOUNT A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday said it expects to cut approximately 1,000 jobs, or about 11% of its workforce, to save costs as the biotech company prepares to launch its newly approved Alzheimer’s drug Leqembi. It’s the

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Health care in focus ‘Ultimate trade-down play’ Watch the Bullpen 1. Health care in focus Club holdings Danaher (DHR) and GE Healthcare (GEHC) reported better-than-expected earnings before the bell Tuesday.

In this article JNJ Follow your favorite stocksCREATE FREE ACCOUNT Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, pose together during the company’s IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023. Brendan McDermid | Reuters Johnson & Johnson on